SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nero who wrote (718)5/6/1998 4:20:00 AM
From: Haolin Ni  Read Replies (1) of 2135
 
Hi, Nero, I am sorry to hear your sad story. You should not compare ENMD with KTEL. Rarely, Biotech stocks have short squeeze if not all because the biothech companies need long time to generate any good news and the big share floating. There are too many biotech companies are developing cancel cure drugs and no one can say for sure which one will be success.

Check the big run up of other biotech companies such as GERN, ONXX, AVIR, etc etc. There are so many longs losing big in stock price run up and they will get out when the pain is unbearable or margin call coming.

KTEL is pushing their price but ENMD and Bristol-Myers are not doing so. Sell you shares now then buy them back at lower price if you really belive ENMD or want to gamble on it. Then, you can claim lose and wait for your profit to come one day.

Best regards!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext